KALV KalVista Pharmaceuticals, Inc.

Fundamentals / CIK 0001348911 / USD

KalVista Pharmaceuticals, Inc. reported $328.9M in total assets and a net loss of $183.4M through April 30, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open KALV in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$68.65M$34.33M$0-$175.8MFY 2016 Revenue: $2.13MFY 2016 Net Income: -$11.44M2016FY 2017 Revenue: $1.50MFY 2017 Net Income: -$18.60M2017FY 2018 Revenue: $8.39MFY 2018 Net Income: -$15.80M2018FY 2019 Revenue: $16.13MFY 2019 Net Income: -$20.82M2019FY 2020 Revenue: $12.69MFY 2020 Net Income: -$29.12M2020FY 2021 Net Income: -$46.24M2021FY 2022 Net Income: -$82.34M2022FY 2023 Net Income: -$92.91M2023FY 2024 Revenue: $50.00MFY 2024 Net Income: -$126.6M2024FY 2025 Net Income: -$183.4M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30
Revenue -- $50.00M -- -- -- $12.69M $16.13M $8.39M $1.50M $2.13M
Research & Development $71.71M $86.17M $80.28M $70.17M $41.29M $40.19M $35.02M $18.24M $12.67M $14.66M
Total Operating Expenses $188.0M $140.4M $110.9M $96.61M $57.92M $53.22M $45.95M $27.10M $23.84M $17.31M
Operating Income -$188.0M -$140.4M -$110.9M -$96.61M -$57.92M -$40.53M -$29.82M -$18.70M -$22.34M -$15.18M
EBITDA -$187.1M -$139.6M -$110.2M -$96.05M -$57.39M -$40.02M -$29.44M -$18.52M -$22.30M -$15.15M
Interest Income $6.43M $3.90M $2.23M $1.09M $903K $1.83M $1.40M $82K $36K $50K
Interest Expense $5.79M -- -- -- -- -- -- -- -- --
Income Before Tax -$180.1M -$126.6M -$92.91M -$82.34M -$82.34M -$29.24M -$20.69M -$15.80M -$18.60M -$11.44M
Income Tax Expense $3.39M $0 $0 $0 $0 -$124K $124K $0 $0 $0
Net Income -$183.4M -$126.6M -$92.91M -$82.34M -$46.24M -$29.12M -$20.82M -$15.80M -$18.60M -$11.44M
Basic EPS -$3.69 -$3.44 -$3.33 -$3.36 -$2.42 -$1.64 -$1.38 -$1.53 -$4.47 -$26.17
Diluted EPS -$3.69 -$3.44 -$3.33 -$3.36 -$2.42 -$1.64 -$1.38 -$1.53 -$4.47 -$26.17
Basic Shares Outstanding 49.7M 36.8M 27.9M 24.5M 19.1M 17.7M 15.1M 10.3M 4.6M 591.3K
Diluted Shares Outstanding 49.7M 36.8M 27.9M 24.5M 19.1M 17.7M 15.1M 10.3M 4.6M 591.3K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-03-31 2025-09-30 2025-07-31 2025-06-30 2025-04-30 2025-03-31 2025-01-31 2024-10-31
Revenue $40.86M $13.70M $1.40M -- -- -- -- --
Cost of Revenue $3.09M $1.23M -- -- -- -- -- --
Gross Profit $37.77M $12.47M -- -- -- -- -- --
Research & Development $12.42M $11.99M $15.16M -- $15.89M $14.17M $12.59M $16.61M
Selling, General & Admin $48.80M $46.52M $44.68M -- -- $35.53M -- --
Total Operating Expenses $64.31M $59.74M $60.44M -- $55.03M $49.71M $42.94M $45.81M
Operating Income -$23.44M -$46.05M -$59.01M -- -$55.03M -$49.71M -$42.94M -$45.81M
EBITDA -$23.09M -- -$58.76M -- -$54.77M -$49.46M -$42.71M -$45.58M
Interest Income $2.55M $1.88M $1.85M -- $1.99M $1.74M $1.39M $1.36M
Interest Expense $5.59M $4.76M $3.52M -- -- $2.94M -- --
Income Before Tax -$23.49M -$47.33M -$57.94M -- -$53.08M -$47.59M -$44.26M --
Income Tax Expense $0 $2.16M $2.16M -- -$855K $4.25M $4.25M --
Net Income -$23.49M -$49.48M -$60.10M -$57.60M -$52.23M -$51.84M -$48.51M -$42.27M
Basic EPS -$0.43 -$0.92 -$1.12 -- -- -$0.98 -$0.92 -$0.91
Diluted EPS -$0.43 -$0.92 -$1.12 -- -- -$0.98 -$0.92 -$0.91
Basic Shares Outstanding 54.6M 53.9M 53.5M -- -- 53.1M 52.6M 46.7M
Diluted Shares Outstanding 54.6M 53.9M 53.5M -- -- 53.1M 52.6M 46.7M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30
Cash & Cash Equivalents $131.6M $31.79M $56.24M $30.73M $50.59M $15.79M $32.01M $51.05M $30.95M $21.76M
Short-Term Investments $89.00M $178.6M $93.14M $135.5M $198.3M $51.92M $68.81M -- -- --
Cash & Short-Term Investments $220.6M $210.4M $149.4M $166.2M $248.9M $67.71M $100.8M $51.05M $30.95M $21.76M
Accounts Receivable, Net $0 -- -- -- -- -- -- -- -- --
Total Current Assets $241.7M $225.7M $172.3M $193.6M $264.3M $88.70M $115.5M $59.38M $34.20M $24.67M
Property, Plant & Equipment, Net $1.99M $2.23M $2.95M $2.18M $1.79M $2.04M $2.41M $1.84M $97K $74K
Other Non-Current Assets $1.55M $567K $106K $193K $200K $178K $173K $173K $50K --
Total Non-Current Assets $9.08M $9.71M $10.88M $10.23M $7.75M $3.83M $2.59M $2.01M $147K $74K
Total Assets $250.8M $235.4M $183.2M $203.9M $272.0M $92.53M $118.1M $61.39M $34.34M $24.75M
Accounts Payable $4.88M $9.11M $4.82M $3.64M $1.98M $1.68M $2.86M $1.43M $1.15M $1.01M
Deferred Revenue (Current) $11.00M -- -- -- -- -- $9.54M $18.48M -- --
Total Current Liabilities $45.17M $22.81M $15.03M $11.58M $9.77M $7.72M $18.05M $23.22M $3.02M $3.25M
Deferred Revenue (Non-Current) -- -- -- -- -- -- $3.34M $10.86M -- --
Total Non-Current Liabilities $110.2M $6.01M $7.14M $7.21M $5.05M $1.06M $3.34M $10.92M $0 $0
Total Liabilities $155.4M $28.82M $22.18M $18.79M $14.82M $8.78M $21.39M $34.14M $3.02M $3.25M
Total Debt (incl. Leases) $6.31M $7.32M $8.23M $8.19M $5.91M $1.65M -- -- -- --
Common Stock $50K $42K $34K $25K $24K $18K $17K $11K $10K --
Retained Earnings -$653.2M -$469.7M -$343.1M -$250.2M -$167.8M -$121.6M -$92.48M -$71.66M -$55.85M -$37.25M
Accumulated Other Comp. Income -$5.21M -$3.49M -$3.06M -$3.86M -$1.43M -$1.88M -$1.93M -$1.11M -$2.64M -$75K
Total Stockholders' Equity $95.39M $206.6M $161.0M $185.1M $257.2M $83.75M $96.74M $27.25M $31.33M -$37.11M
Total Equity $95.39M $206.6M $161.0M $185.1M $257.2M $83.75M $96.74M $27.25M $31.33M -$37.11M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-03-31 2025-12-31 2025-09-30 2025-07-31 2025-04-30 2025-01-31 2024-12-31 2024-10-31
Cash & Cash Equivalents $213.8M $229.3M $243.5M $124.3M $131.6M $167.3M $182.3M $41.58M
Short-Term Investments $71.26M $70.87M $65.66M $67.16M $89.00M $85.92M $86.02M $94.19M
Cash & Short-Term Investments $285.0M $300.2M $309.2M $191.5M $220.6M $253.2M $268.3M $135.8M
Accounts Receivable, Net $9.90M $2.59M $5.78M $1.93M $0 -- $0 --
Inventory $4.00M $3.43M $458K -- -- -- -- --
Total Current Assets $314.2M $320.1M $325.2M $205.9M $241.7M $267.4M $286.0M $152.3M
Property, Plant & Equipment, Net $2.84M $3.03M $3.19M $2.07M $1.99M $1.81M $1.88M $2.04M
Other Non-Current Assets $2.45M $2.37M $2.42M $2.38M $1.55M $1.39M $1.38M $662K
Total Non-Current Assets $14.71M $15.23M $14.71M $9.61M $9.08M $8.63M $8.84M $8.56M
Total Assets $328.9M $335.4M $339.9M $215.5M $250.8M $276.0M $294.8M $160.8M
Accounts Payable $8.04M $8.27M $8.07M $5.87M $4.88M $5.86M $5.73M $5.20M
Deferred Revenue (Current) $833K -- $11.51M $11.41M $11.00M -- -- --
Total Current Liabilities $60.82M $57.35M $45.07M $38.38M $45.17M $25.61M $26.11M $22.16M
Long-Term Debt $172.2M -- -- -- -- -- -- --
Deferred Revenue (Non-Current) $21.36M $11.71M -- -- -- -- -- --
Total Non-Current Liabilities $287.8M $280.7M $277.9M $136.3M $110.2M $105.3M $104.3M $4.67M
Total Liabilities $348.6M $338.1M $322.9M $174.7M $155.4M $130.9M $130.5M $26.84M
Total Debt (incl. Leases) $184.3M $12.35M $10.56M $6.14M $6.31M $5.78M $5.89M $5.78M
Common Stock $51K $51K $50K $50K $50K $49K $49K $43K
Retained Earnings -$786.2M -$762.7M -$739.1M -$713.3M -$653.2M -$600.9M -$580.2M -$552.4M
Accumulated Other Comp. Income -$7.12M -$7.13M -$6.73M -$6.39M -$5.21M -$2.21M -$2.42M -$2.70M
Total Stockholders' Equity -$19.65M -$2.71M $17.00M $40.79M $95.39M $145.1M $164.4M $134.0M
Total Equity -$19.65M -$2.71M $17.00M $40.79M $95.39M $145.1M $164.4M $134.0M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30
Net Income -$183.4M -$126.6M -$92.91M -$82.34M -$46.24M -$29.12M -$20.82M -$15.80M -$18.60M -$11.44M
Depreciation & Amortization $941K $816K $718K $564K $537K $512K $378K $180K $40K $33K
Stock-Based Compensation $12.29M $21.91M $9.92M $11.09M $7.12M $4.45M $2.97M $1.06M $394K $118K
Change in Payables -$4.97M $4.32M $1.11M $1.69M $150K -$1.00M $1.53M $217K -$1.60M $374K
Operating Cash Flow -$152.9M -$89.23M -$75.26M -$78.13M -$30.17M -$44.82M -$36.37M $10.56M -$23.72M -$13.16M
Capital Expenditure -$434K -$42K -$1.20M -$931K -$82K -$220K -$1.08M -$1.43M -$74K -$11K
Free Cash Flow -$153.3M -$89.27M -$76.46M -$79.06M -$30.25M -$45.04M -$37.45M $9.13M -$23.80M -$13.17M
Purchases of Investments -$30.57M -$189.2M -$98.25M -$136.9M -$201.2M -$49.80M -$79.89M -- -- --
Investing Cash Flow $91.02M -$84.72M $41.41M $57.86M -$147.7M $16.75M -$69.42M -$1.43M $34.06M -$11K
Common Stock Issued $55.91M $96.94M $56.58M -- $210.6M $11.42M $87.91M $9.14M $2.0K $1.0K
Financing Cash Flow $159.7M $150.7M $58.12M $1.58M $212.1M $11.58M $87.94M $8.99M $2.0K $33.00M
Net Change in Cash $100.5M -$24.45M $25.51M -$19.86M $34.80M -$16.22M -$19.05M $20.11M $9.19M $19.24M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-03-31 2025-09-30 2025-07-31 2025-06-30 2025-04-30 2025-03-31 2025-01-31 2024-10-31
Net Income -$23.49M -$49.48M -$60.10M -$57.60M -$52.23M -$51.84M -$48.51M -$42.27M
Depreciation & Amortization $355K -- $252K -- $261K $251K $229K $227K
Stock-Based Compensation $5.07M -- $5.38M -- $3.64M $3.24M $2.61M $3.00M
Change in Receivables -$7.32M -- -$1.93M -- -- -- -- --
Change in Inventory -$665K -- -- -- -- -- -- --
Change in Payables -$149K -- $2.51M -- -$1.39M -$3.12M $779K -$5.86M
Operating Cash Flow -$14.46M -- -$54.50M -- -$40.36M -$47.57M -$32.68M -$39.64M
Capital Expenditure -$121K -- -$290K -- -$281K -$288K -$24K -$108K
Free Cash Flow -$14.58M -- -$54.79M -- -$40.65M -$47.85M -$32.70M -$39.75M
Purchases of Investments -$16.43M -- -$19.98M -- -$23.02M -$23.49M -$6.56M -$1.0K
Investing Cash Flow -$901K -- $21.26M -- -$3.33M -$3.72M $8.52M $48.67M
Financing Cash Flow $1.47M -- $23.21M -- $4.66M $2.22M $151.8M $295K
Net Change in Cash -$15.57M -- -$7.31M -- -$35.67M -$46.82M $126.4M $9.73M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30
Operating Margin -- -280.9% -- -- -- -319.4% -184.9% -222.8% -1485.3% -711.7%
Net Profit Margin -- -253.3% -- -- -- -229.4% -129.1% -188.3% -1236.9% -536.1%
Return on Equity (ROE) -192.3% -61.3% -57.7% -44.5% -18.0% -34.8% -21.5% -58.0% -59.4% --
Return on Assets (ROA) -73.2% -53.8% -50.7% -40.4% -17.0% -31.5% -17.6% -25.7% -54.2% -46.2%
Current Ratio 5.35x 9.90x 11.46x 16.73x 27.04x 11.49x 6.40x 2.56x 11.33x 7.59x
Quick Ratio 4.88x 9.23x 9.94x 14.36x 25.47x 8.77x 5.58x 2.20x 10.26x 6.70x
Debt to Equity 0.07x 0.04x 0.05x 0.04x 0.02x 0.02x -- -- -- --
Revenue Growth (YoY) -- -- -- -- -- -21.3% +92.1% +458.1% -29.5% --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -444.4% -- -- --
Free Cash Flow Growth (YoY) -- -- -- -- -- -- -510.1% -- -- --
5Y Revenue / Share Growth -- +27.1% -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-03-31 2025-09-30 2025-07-31 2025-06-30 2025-04-30 2025-03-31 2025-01-31 2024-10-31
Return on Assets (ROA) -58.0% -- -- -- -- -- -- --
Current Ratio 5.17x 7.22x 5.37x 5.37x 5.35x 5.35x 10.44x 6.87x
Quick Ratio 5.10x 7.21x 5.04x 5.04x 4.88x 4.88x 9.88x 6.13x
Debt to Equity -- 0.62x 0.15x 0.15x 0.07x 0.07x 0.04x 0.04x
Source: SEC EDGAR CompanyFacts (CIK 0001348911) · from December 31, 2013 Data through March 31, 2026 · synced Nov 20, 2026, 05:26 UTC · Open in terminal